Cetuximab plus XELIRI or XELOX for First-Line Therapy of Metastatic Colorectal Cancer-Reference-Cited by-同舟云学术

Cetuximab plus XELIRI or XELOX for First-Line Therapy of Metastatic Colorectal Cancer

Published:2008-03 Issue:2 Volume:7 Page:110-117
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Moosmann Nicolas,Heinemann Volker

Publisher

Elsevier BV

Subject

Gastroenterology,Oncology

Reference55 articles.

1. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer;Goldberg;J Clin Oncol,2004

2. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer;de Gramont;J Clin Oncol,2000

3. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study;Tournigand;J Clin Oncol,2004

4. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study;Hoff;J Clin Oncol,2001

5. Cetuximab plus FOLFOX6 as first-line therapy for metastatic colorectal cancer (an International Oncology Network study, I-03-002);Dakhil;J Clin Oncol,2006

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug combinations of camptothecin derivatives promote the antitumor properties;European Journal of Medicinal Chemistry;2024-09

2. Biweekly cetuximab in combination with capecitabine and oxaliplatin (XELOX) or irinotecan (XELIRI) in the first-line and second-line treatment of patients with RAS wild-type metastatic colorectal cancer;ecancermedicalscience;2022-12-15

3. Severe interstitial pneumonia caused by cetuximab: a case report and review of the literature;Anti-Cancer Drugs;2021-07-12

4. Analysis of surgical complications of primary tumor resection after neoadjuvant treatment in stage IV colon cancer;J GASTROINTEST ONCOL;2014

5. Chronochimiothérapie à base de 5-fluorouracil, acide folinique et oxaliplatine administrée en deux jours toutes les deux semaines pour le cancer colorectal. L’expérience du CHC-Liège (Belgique);Pathologie Biologie;2013-10